Literature DB >> 17547687

Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women.

G De Pergola1, A Ciampolillo, S Paolotti, P Trerotoli, R Giorgino.   

Abstract

OBJECTIVE: To examine whether obesity, body fat distribution and insulin resistance have an independent effect on serum TSH and free thyroid hormones (FT3 and FT4) in a cohort of euthyroid women, represented by overweight and obese patients. DESIGN AND PATIENTS: A total of 201 women, aged 18-68 years, with body mass index (BMI) > or = 25.0 kg/m(2) and TSH levels < 4.0 mU/l were investigated. MEASUREMENTS: Fasting TSH, FT3, FT4, insulin, glucose, and serum lipid concentrations, and the level of insulin resistance, estimated by the homeostasis model assessment for insulin resistance (HOMA-IR). Waist circumference was measured as an indirect parameter of central fat accumulation.
RESULTS: FT3 was directly associated with BMI (P < 0.01) and waist circumference (P < 0.01), and negatively correlated with age (P < 0.001). FT4 was negatively associated with HOMA-IR (P < 0.05) and fasting insulin levels (P < 0.05). TSH was positively correlated with waist circumference (P < 0.05) and negatively associated with age (P < 0.05). When multiple regression analysis was performed with FT3 as the dependent variable, and waist circumference, HOMA-IR, blood pressure levels and serum lipid concentrations as independent variables, FT3 maintained an independent association only with waist circumference (positive, P < 0.05) and age (negative, P < 0.001). When multiple regression analysis was performed with TSH as the dependent variable, and the above parameters as independent variables, TSH maintained an independent association only with waist circumference (positive, P < 0.05) and age (negative, P < 0.05). By contrast, when multiple regression analysis was performed with FT4 as the dependent variable, FT4 did not maintain an independent association with any of the independent parameters.
CONCLUSIONS: Progressive central fat accumulation is associated with an increase in both FT3 and TSH serum levels, independently of insulin sensitivity, metabolic parameters and blood pressure. These results suggest that (1) progressive central fat accumulation is associated with a parallel increase in FT3 levels, possibly as an adaptive thermogenic phenomenon, and (2) the control of TSH secretion by free thyroid hormones is possibly impaired in obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17547687     DOI: 10.1111/j.1365-2265.2007.02874.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  83 in total

1.  Relationship of thyroid function with body mass index and insulin-resistance in euthyroid obese subjects.

Authors:  B Ambrosi; B Masserini; L Iorio; A Delnevo; A E Malavazos; L Morricone; L F Sburlati; E Orsi
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

2.  Morbid obesity in women is associated to a lower prevalence of thyroid nodules.

Authors:  Carlo Cappelli; Ilenia Pirola; Francesco Mittempergher; Elvira De Martino; Claudio Casella; Barbara Agosti; Riccardo Nascimbeni; Annamaria Formenti; Enrico Agabiti Rosei; Maurizio Castellano
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

3.  A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine.

Authors:  Vijay Panicker; Christie Cluett; Beverley Shields; Anna Murray; Kirstie S Parnell; John R B Perry; Michael N Weedon; Andrew Singleton; Dena Hernandez; Jonathan Evans; Claire Durant; Luigi Ferrucci; David Melzer; Ponnusamy Saravanan; Theo J Visser; Graziano Ceresini; Andrew T Hattersley; Bijay Vaidya; Colin M Dayan; Timothy M Frayling
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

Review 4.  Bioenergetic impact of tissue-specific regulation of iodothyronine deiodinases during nutritional imbalance.

Authors:  Renata L Araujo; Denise P Carvalho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

5.  Relationship between metabolic syndrome and thyroid nodules and thyroid volume in an adult population.

Authors:  Wenxing Guo; Long Tan; Wen Chen; Lili Fan; Yanting Chen; Cong Du; Mei Zhu; Hongyan Wei; Wei Wang; Min Gao; Tingkai Cui; Jun Shen; Wanqi Zhang
Journal:  Endocrine       Date:  2019-03-27       Impact factor: 3.633

6.  Hormetic effect of triiodothyronine in metabolically healthy obese persons.

Authors:  Ji Eun Jun; Tae Hyuk Kim; Seung-Eun Lee; You-Bin Lee; Jae Hwan Jee; Ji Cheol Bae; Sang-Man Jin; Kyu Yeon Hur; Jae Hyeon Kim; Sun Wook Kim; Jae Hoon Chung; Yong-Ki Min; Moon-Kyu Lee
Journal:  Endocrine       Date:  2017-07-19       Impact factor: 3.633

7.  Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study.

Authors:  Cari L Meinhold; Elaine Ron; Sara J Schonfeld; Bruce H Alexander; D Michal Freedman; Martha S Linet; Amy Berrington de González
Journal:  Am J Epidemiol       Date:  2009-11-30       Impact factor: 4.897

8.  Raised serum TSH in morbid-obese and non-obese patients: effect on the circulating lipid profile.

Authors:  Mario Rotondi; Paola Leporati; Maria Ileana Rizza; Alessandra Clerici; Gloria Groppelli; Cristina Pallavicini; Antonella La Manna; Rodolfo Fonte; Flavia Magri; Bernadette Biondi; Luca Chiovato
Journal:  Endocrine       Date:  2013-03-23       Impact factor: 3.633

9.  Thyroid function derangement and childhood obesity: an Italian experience.

Authors:  Anna Grandone; Nicola Santoro; Filomena Coppola; Paolo Calabrò; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  BMC Endocr Disord       Date:  2010-05-04       Impact factor: 2.763

Review 10.  Endocrine changes (beyond diabetes) after bariatric surgery in adult life.

Authors:  S Savastano; C Di Somma; R Pivonello; G Tarantino; F Orio; V Nedi; A Colao
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.